Fludarabine and Cytarabine as Continuous Infusion Plus G-CSF Priming for Elderly Patients With Resistant AML.
Phase of Trial: Phase II
Latest Information Update: 27 Feb 2017
At a glance
- Drugs Cytarabine (Primary) ; Fludarabine (Primary) ; Lenograstim
- Indications Acute myeloid leukaemia
- Focus Therapeutic Use
- 02 Oct 2007 New trial record.